Chaperone-Dependent Mechanisms as a Pharmacological Target for Neuroprotection
International Journal of Molecular Sciences · 03.01.2023 · 24 (1) · 823
DOI: 10.3390/ijms24010823 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.01.2023. Verfasst von Mikhail V Voronin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacogenetics, FSBI "Zakusov Institute of Pharmacology", Baltiyskaya Street 8, 125315 Moscow, Russia. Hauptthemen laut MEDLINE: Neuroprotective Agents, Neurodegenerative Diseases. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 473 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
Modern pharmacotherapy of neurodegenerative diseases is predominantly symptomatic and does not allow vicious circles causing disease development to break. Protein misfolding is considered the most important pathogenetic factor of neurodegenerative diseases. Physiological mechanisms related to the function of chaperones, which contribute to the restoration of native conformation of functionally important proteins, evolved evolutionarily. These mechanisms can be considered promising for pharmacological regulation. Therefore, the aim of this review was to analyze the mechanisms of endoplasmic reticulum stress (ER stress) and unfolded protein response (UPR) in the pathogenesis of neurodegenerative diseases. Data on BiP and Sigma1R chaperones in clinical and experimental studies of Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and Huntington’s disease are presented. The possibility of neuroprotective effect dependent on Sigma1R ligand activation in these diseases is also demonstrated. The interaction between Sigma1R and BiP-associated signaling in the neuroprotection is discussed. The performed analysis suggests the feasibility of pharmacological regulation of chaperone function, possibility of ligand activation of Sigma1R in order to achieve a neuroprotective effect, and the need for further studies of the conjugation of cellular mechanisms controlled by Sigma1R and BiP chaperones.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacogenetics, FSBI "Zakusov Institute of Pharmacology", Baltiyskaya Street 8, 125315 Moscow, Russia.
ORCID-Profile: Mikhail V Voronin, Ekaterina R Verbovaya, Yulia V Vakhitova, Sergei B Seredenin
Förderung
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Voronin, M. V., Abramova, E. V., Verbovaya, E. R., Vakhitova, Y. V., & Seredenin, S. B. (2023). Chaperone-Dependent Mechanisms as a Pharmacological Target for Neuroprotection. International Journal of Molecular Sciences, 24(1), 823. https://doi.org/10.3390/ijms24010823
Vancouver
Voronin MV, Abramova EV, Verbovaya ER, Vakhitova YV, Seredenin SB. Chaperone-Dependent Mechanisms as a Pharmacological Target for Neuroprotection. International Journal of Molecular Sciences. 2023;24(1):823. doi:10.3390/ijms24010823
BibTeX
@article{Voronin2023,
author = {Voronin, Mikhail V and Abramova, Elena V and Verbovaya, Ekaterina R and Vakhitova, Yulia V and Seredenin, Sergei B},
title = {Chaperone-Dependent Mechanisms as a Pharmacological Target for Neuroprotection},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {1},
pages = {823},
doi = {10.3390/ijms24010823}
}
EUVIMED